世界の移植片対宿主病治療薬市場...市場調査レポートについてご紹介

【英文タイトル】OpportunityAnalyzer: Graft-Versus-Host Disease - Opportunity Analysis and Forecasts to 2018

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 12
1.1 List of Tables 18
1.2 List of Figures 22
2 Introduction 23
2.1 Catalyst 23
2.2 Related Reports 24
2.3 Upcoming Related Reports 24
3 Disease Overview 25
3.1 Etiology and Pathophysiology 25
3.1.1 Etiology 25
3.1.2 Pathophysiology 27
3.1.3 Classification and Prognosis 28
3.2 Symptoms 30
4 Epidemiology 32
4.1 Disease Background 32
4.2 Risk Factors and Comorbidities 33
4.3 Global Trends 35
4.4 Forecast Methodology 36
4.4.1 Sources Used 38
4.4.2 Sources Not Used 44
4.4.3 Diagnosed Incident Cases of HSCTs 45
4.4.4 Diagnosed Incident Cases of Autologous HSCTs 47
4.4.5 Diagnosed Incident Cases of Allogeneic HSCTs 48
4.4.6 Diagnosed Incident Cases of aGVHD 49
4.4.7 Four-Year Diagnosed Prevalent Cases of aGVHD 49
4.4.8 Diagnosed Incident Cases of cGVHD 50
4.4.9 Five-Year Diagnosed Prevalent Cases of cGVHD 50
4.5 Epidemiological Forecast for GVHD (2013-2023) 51
4.5.1 Diagnosed Incident Cases of HSCTs 51
4.5.2 Diagnosed Incident Cases of Autologous HSCTs 53
4.5.3 Diagnosed Incident Cases of Allogeneic HSCTs 54
4.5.4 Diagnosed Incident Cases of aGVHD 56
4.5.5 Four-Year Diagnosed Prevalent Cases of aGVHD 58
4.5.6 Diagnosed Incident Cases of cGVHD 60
4.5.7 Five-Year Diagnosed Prevalent Cases of cGVHD 61
4.6 Discussion 63
4.6.1 Epidemiological Forecast Insight 63
4.6.2 Limitations of the Analysis 64
4.6.3 Strengths of the Analysis 65
5 Current Treatment Options 66
5.1 Overview 66
5.2 Product Profiles – Major Therapies 68
5.2.1 Methylprednisolone (numerous brand and generic names) 68
5.2.2 Cyclosporine (numerous brands and generic names) 72
5.2.3 Anti-Thymocyte Globulin (ATG) Therapies 77
5.3 Product Profiles – Off-Label Therapies 82
5.3.1 Biologics (Tumor Necrosis Factor (TNF)α Inhibitors, Interleukin-2 Receptor α (CD25) Inhibitors, Co-Stimulatory Blockers and Other Biologics) 82
5.3.2 Small Immunosuppressive Molecules (mTOR Inhibitors, Solid Organ Transplant Therapies, and Anti-Neoplastic Therapies) 101
6 Unmet Need and Opportunity 116
6.1 Overview 116
6.2 Lack of Randomized Clinical Trials 119
6.2.1 Unmet Need 119
6.2.2 Gap Analysis 119
6.2.3 Opportunity 120
6.3 No Consensus Regarding Clinical Trial Endpoints 120
6.3.1 Unmet Need 120
6.3.2 Gap Analysis 120
6.3.3 Opportunity 121
6.4 Optimization of Prophylactic Measures 121
6.4.1 Unmet Need 121
6.4.2 Gap Analysis 122
6.4.3 Opportunity 122
6.5 Lack of Standardized Protocols for Established and Off-Label Therapies 123
6.5.1 Unmet Need 123
6.5.2 Gap Analysis 123
6.5.3 Opportunity 124
6.6 Improved Treatment Outcomes for Patients Who Develop Toxicities 124
6.6.1 Unmet Need 124
6.6.2 Gap Analysis 125
6.6.3 Opportunity 125
6.7 Desire for Treatments that Exhibit Longer-Lasting Efficacy Profiles 125
6.7.1 Unmet Need 125
6.7.2 Gap Analysis 126
6.7.3 Opportunity 127
6.8 Management of SR-aGVHD Patients 127
6.8.1 Unmet Need 127
6.8.2 Gap Analysis 128
6.8.3 Opportunity 128
6.9 Management of Sclerotic cGVHD Patients 128
6.9.1 Unmet Need 128
6.9.2 Gap Analysis 129
6.9.3 Opportunity 129
6.10 Improved Prognosis for Patients with Lung Involvement 130
6.10.1 Unmet Need 130
6.10.2 Gap Analysis 130
6.10.3 Opportunity 131
7 Research and Development Strategies 132
7.1 Overview 132
7.1.1 Improvement of Prophylactic Regimens 132
7.1.2 Inhibition of T-Cell Proliferation and Activation 133
7.1.3 Adopting Treatments from Hematologic Indications 134
7.1.4 Targeting Niche Subgroups Within GVHD 135
7.2 Current Clinical Trial Design 136
7.2.1 Current Trial Designs are Dependent on the Stage Within the Treatment Algorithm That a Product is Targeting 136
7.2.2 Lack of Consensus on Clinical Endpoints in Current Trial Designs 137
7.2.3 Patient Exclusion Issues in Current Trial Designs 137
7.2.4 Current Trial Design of Key Pipeline Products 137
7.3 Future Clinical Trial Design 139
7.3.1 Future Trial Designs Need to Incorporate Randomization 139
7.3.2 Future Trial Designs Need to Incorporate Conditioning Regimens and Hematological Patients 140
7.3.3 Companies Behind Off-Label Therapies Should Strategize to Conduct Randomized Studies 140
7.3.4 Design of Early-Phase Clinical Trials for Cellular and Gene Therapy Products Accommodates 2014 Guidance from the FDA 140
8 Pipeline Assessment 141
8.1 Overview 141
8.2 Promising Drugs in Clinical Development 142
8.2.1 Leukotac (inolimomab) 142
8.2.2 Begedina (BT 5/9) 147
8.2.3 Budenofalk (budesonide) 150
8.2.4 ATG-Fresenius (EZ-2053) 153
8.2.5 Prochymal (remestemcel-L) 156
8.2.6 MultiStem (modified mesenchymal stem cells) 161
8.2.7 Uvadex (Extracorporeal Photophoresis) 164
8.2.8 orBec (beclomethasone dipropionate) 168
8.3 Innovative Early-Stage Approaches 171
8.3.1 Targeting Regulatory T Cells 174
8.3.2 Mesenchymal Stem Cell Therapies 175
8.3.3 Immunomodulatory Cell Surface Receptor Inhibitors 176
8.3.4 IL-6 Inhibitors 177
9 Pipeline and Off-Label Valuation Analysis 178
9.1 Clinical Benchmarking of Key Pipeline and Off-Label Drugs 178
9.1.1 GVHD Prophylaxis 178
9.1.2 Acute GVHD 181
9.1.3 Chronic GVHD 185
9.2 Commercial Benchmarking of Key Pipeline and Off-Label Drugs 186
9.2.1 GVHD Prophylaxis 187
9.2.2 Acute GVHD 189
9.2.3 Chronic GVHD 191
9.3 Competitive Assessment 193
9.3.1 GVHD Prophylaxis 193
9.3.2 Acute GVHD 194
9.3.3 Chronic GVHD 196
9.4 Top-Line Five-Year Forecast 198
9.4.1 US 203
9.4.2 5EU 207
10 Appendix 211
10.1 Bibliography 211
10.2 Abbreviations 230
10.3 Methodology 236
10.4 Forecasting Methodology 236
10.4.1 Diagnosed GVHD Patients 236
10.4.2 Percent Drug-Treated Patients 237
10.4.3 Drugs Included in Each Therapeutic Class 237
10.4.4 Launch and Patent Expiry Dates 238
10.4.5 General Pricing Assumptions 238
10.4.6 Individual Drug Assumptions 239
10.4.7 Generic Erosion 246
10.4.8 Pricing of Pipeline Agents 246
10.5 Physicians and Specialists Included in This Study 247
10.6 About the Authors 249
10.6.1 Author 249
10.6.2 Reviewer 249
10.6.3 Epidemiologist 250
10.6.4 Global Head of Healthcare 250
10.7 About GlobalData 251
10.8 Disclaimer 251


【レポート販売概要】

■ タイトル:世界の移植片対宿主病治療薬市場
■ 英文:OpportunityAnalyzer: Graft-Versus-Host Disease - Opportunity Analysis and Forecasts to 2018
■ 発行日:2014年8月20日
■ 調査会社:GlobalData
■ 商品コード:GDHC021POA
■ 調査対象地域:グローバル
  • 感染症検査の世界市場2015
    This report provides a worldwide overview of the infectious disease testing market environment, structure, size and growth. Includes estimates of the number of laboratories performing infectious disease tests, as well as ten-year test volume and sales forecasts by country.Contains 15 pages and 3 tables
  • 世界の商用ビル・オートメーション市場動向(2012-2016)
    TechNavio's analysts forecast the Global Commercial Building Automation market to grow at a CAGR of 3.64 percent over the period 2012-2016. One of the key factors contributing to this market growth is the need for improved safety systems. The Global Commercial Building Automation market has also been witnessing the increasing adoption of wireless commercial building automation systems. However, th …
  • 自動車用セルモーターの世界市場
    About Automotive Starter MotorA car engine is turned on at a high speed to suck in air and fuel into the combustion chamber for compression. The starter motor comprises a pinion on its shaft, which is fixed to the larger sun gear ring on the flywheel. The starter motor provides rotatory motion and cranks, and provides ignition to the engine. Technavio’s analysts forecast the global automotive star …
  • リファビッシュ医療機器の世界市場2015-2019
    Refurbished Medical Equipment Refurbishment is a process that ensures the safety and effectiveness of medical equipment without changing the performance of these equipment. Refurbishment is used to maintain the used equipment into its original condition. Unlike remanufacturing, refurbishment does not alter any product specification; it just restore used medical equipment or systems into a conditio …
  • 中国の乗用車市場:セダン・小型車、SUV/クロスオーバー、MPV、高級車
    About the Passenger Vehicle Market in China China is leading the global automotive industry since 2009, when it overtook the US in terms of total vehicle production. China represents one of the fastest-growing auto industries and is one of the key regions for original equipment manufacturers (OEMs) across the globe. Passenger cars are a key segment of the automotive industry in China. This segment …
  • 電磁弁(ソレノイドバルブ)の世界市場予測(~2022)
    The global solenoid valve market is expected to grow from USD 3.44 Billion in 2015 to USD 4.41 Billion by 2022, at a CAGR of 3.54% during the forecast period. The market registered a shipment of 12.94 million units in 2015 and is expected to reach 20.29 million units by 2022. The major factors driving the market include growing adoption of solenoid valves in various process industries and increasi …
  • 3Dプリンター用素材の世界市場:樹脂、金属、セラミック、その他
    The 3D printing materials market size in terms of value is projected to grow at a CAGR of 20.4% between 2014 and 2019 to reach $1.052 million by 2019. North America held the largest share in 3D printing materials market in 2013. Major growth in the North American region is expected from the consumer & industrial application. The 3D printing materials market in North America is growing fast, mainly …
  • クラウド・プロフェッショナルサービスの世界市場2015-2019
    About Global Cloud Professional Services An increased number of cloud solutions from various vendors have created a complex cloud environment. Cloud customers are struggling with integrating and managing applications, workloads, cloud stacks, and other facets of the shift to cloud. They are spending heavily on consultants and system integrators to educate, plan, and implement their cloud environme …
  • コンテンツデリバリーネットワーク(CDN)の世界市場
    ABSTRACTAbout Content Delivery Network CDN is a large distributed system of servers deployed in multiple data centers across the Internet. CDN aims to make contents easily available to end-users with a high performance of websites. CDNs serve a large fraction of the Internet content, which includes web objects like text, graphics, URLs, scripts, and downloadable objects such as media files, softwa …
  • 防水システムの東南アジア市場:既成膜(変性瀝青、PVC、TPO、EPDM)、塗膜(エラストマー、セメント混合、歴青質)、統合システム(ポアブロッキング剤、結晶防水剤)、防水化学品 (瀝青、エラストマー、PVC、TPO、EPDM、コンクリート)
    The market size of Southeast Asia waterproofing systems market is estimated to reach USD 5.35 Billion by 2021, at a CAGR of 14.52% during the forecast period. The rising demand for waterproofing is backed by the growing building & construction industry in the region, especially in the developing countries, such as Indonesia, Malaysia, Thailand, Singapore, and Vietnam. Rapid growth in the construct …
  • 世界の石油・ガス産業における高度プロセス制御(APC)ソフトウェア市場
    About APC APC software is an integrated tool used to increase the efficiency of process management and plant operations. Many organizations across various process industries such as chemical, oil and gas, petrochemical, power, pharmaceutical, pulp and paper, and food and beverage use APC software to optimize their resource utilization and enhance their organizational productivity. The effective de …
  • 乳癌治療のグローバル市場:画期的新薬の発見と商用化
    Frontier Pharma: Breast Cancer - Identifying and Commercializing First-in-Class Innovation Summary Exceptionally Large and Innovative Pipeline The breast cancer pipeline is the largest in the pharmaceutical industry with 815 products in active development across all stages. The range of mechanisms of action employed by these compounds is also highly diverse, especially in comparison to the existin …
  • 世界のマルチファンクションディスプレイ(MFD)市場(2014 – 2020)
    Report Description This report provides a market analysis of the multi-function display market over the next five years. It contains an analysis of the drivers, challenges, and restraints that affect the industry, along with their impact in the short, medium, and long term landscapes. It also discusses the industry, market, and technology trends that currently prevail in the market. The report pro …
  • 世界のウォータジェット加工機市場2015
    Global Waterjet Machine Industry Report 2015is a professional and in-depth study on the current state of theWaterjet Machine industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. TheWaterjet Machine market analysis is provided for the China markets including development trends, competitive landscape analysi …
  • 自動車用鉛蓄電池の世界市場予測(~2021年)
    The global automotive lead acid batteries market is projected to reach USD 45.03 Billion by 2021, at a CAGR of 4.8% between 2016 and 2021. The growth of this market can be attributed to the growing demand from the automotive industry and the used vehicles in the developed economies, including China and the U.S. The passenger cars segment dominated the global automotive lead acid batteries market i …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。